QUANTITATIVE RETENTION OF MAGMATIC ARGON IN A GLASSY BASALTFISHER DAVID E.1981; NATURE (LONDON); ISSN 0028-0836; GBR; DA. 1981-03-05; VOL. 290; NO 5801; PP. 42-43; BIBL. 24 REF.; 11 ANAL.; 1 TAB. ; ILL.Article

Transcriptional Regulation in MelanomaMITRA, Devarati; FISHER, David E.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, viii, 447-465 [19 p.]Article

Advances in MelanomaFISHER, David E.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, 259 p.Serial Issue

Biology and Clinical Relevance of the Micropthalmia Family of Transcription Factors in Human CancerHAQ, Rizwan; FISHER, David E.Journal of clinical oncology. 2011, Vol 29, Num 25, pp 3474-3482, issn 0732-183X, 9 p.Article

Progress in Melanoma Histopathology and DiagnosisPIRIS, Adriano; MIHM, Martin C.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, viii, 467-480 [14 p.]Article

Melanoma Early DetectionTERUSHKIN, Vitaly; HALPERN, Allan C.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, viiii, 481-500 [20 p.]Article

Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and functionHERSHEY, Christine L; FISHER, David E.Bone (New York, NY). 2004, Vol 34, Num 4, pp 689-696, issn 8756-3282, 8 p.Article

Induction of apoptosis in cancer: new therapeutic opportunities : ApoptosisDING, Han-Fei; FISHER, David E.Annals of medicine (Helsinki). 2002, Vol 34, Num 6, pp 451-469, issn 0785-3890, 19 p.Article

TumorAngiogenesis in MelanomaMARNEROS, Alexander G.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, xiii-viii, 431-446 [19 p.]Article

The Classification of Cutaneous MelanomaMCDIVITT DUNCAN, Lyn.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, ix, 501-513 [13 p.]Article

Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survivalWIDLUND, Hans R; FISHER, David E.Oncogene (Basingstoke). 2003, Vol 22, Num 20, pp 3035-3041, issn 0950-9232, 7 p.Article

New Strategies in Metastatic Melanoma: Oncogene-Defined Taxonomy Leads to Therapeutic AdvancesFLAHERTY, Keith T; FISHER, David E.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 4922-4928, issn 1078-0432, 7 p.Article

BRAF Signaling and Targeted Therapies in MelanomaDHOMEN, Nathalie; MARAIS, Richard.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, ix, 529-545 [17 p.]Article

Surgical Management of MelanomaWARGO, Jennifer A; TANABE, Kenneth.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, x, 565-581 [18 p.]Article

p53, caspase 8, and regulation of apoptosis after ionizing radiationDING, Han-Fei; FISHER, David E.Journal of pediatric hematology/oncology. 2001, Vol 23, Num 3, pp 185-188, issn 1077-4114Article

Melanoma EpidemiologyTUCKER, Margaret A.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, xiii, 383-395 [15 p.]Article

Educational and Screening Campaigns to Reduce Deaths from MelanomaGELLER, Alan C.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, ix, 515-527 [14 p.]Article

From suntan to skin cancers : molecular pathways and prevention strategiesFISHER, Jonathan M; FISHER, David E.Targeted oncology. 2008, Vol 3, Num 1, pp 41-44, issn 1776-2596, 4 p.Article

Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating Oxidative PhosphorylationHAQ, Rizwan; FISHER, David E; WIDLUND, Hans R et al.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2257-2263, issn 1078-0432, 7 p.Article

Melanocyte biology and skin pigmentation : Skin biologyLIN, Jennifer Y; FISHER, David E.Nature (London). 2007, Vol 445, Num 7130, pp 843-850, issn 0028-0836, 8 p.Article

An Oncogenic Role for ETV1 in MelanomaJANE-VALBUENA, Judit; WIDLUND, Hans R; HAHN, William C et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 5, pp 2075-2084, issn 0008-5472, 10 p.Article

The History and Future of Chemotherapy for MelanomaYANG, Arvin S; CHAPMAN, Paul B.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, x, 583-597 [16 p.]Article

Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimensDORVAULT, Christine C; WEILBAECHER, Katherine N; YEE, Herman et al.Cancer. 2001, Vol 93, Num 5, pp 337-343, issn 0008-543XConference Paper

Phosphatase-Dependent and -Independent Functions of Shp2 in Neural Crest Cells Underlie LEOPARD Syndrome PathogenesisSTEWART, Rodney A; SANDA, Takaomi; NEEL, Benjamin G et al.Developmental cell. 2010, Vol 18, Num 5, pp 750-762, issn 1534-5807, 13 p.Article

Imatinib Targeting of KIT-Mutant Oncoprotein in MelanomaXIAOFENG JIANG; JUN ZHOU; YUEN, Noah K et al.Clinical cancer research (Print). 2008, Vol 14, Num 23, pp 7726-7732, issn 1078-0432, 7 p.Article